This inventor holds 2 USPTO granted patents. Top assignee: Tionlab Therapeutics. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Duck Soo Lim: Innovator in Drug Delivery Systems
Introduction
Duck Soo Lim is a prominent inventor based in Suwon, South Korea. He has made significant contributions to the field of drug delivery systems, focusing on innovative compositions that enhance the effectiveness of therapeutic agents. With a total of 2 patents, Lim's work is paving the way for advancements in medical treatments.
Latest Patents
One of Duck Soo Lim's latest patents is titled "LIPOPROTEIN-MIMICKING SOLID LIPID NANOPARTICLES FOR DRUG DELIVERY AND USES THEREOF." This patent addresses the development of solid lipid nanoparticles that mimic lipoproteins, which can improve drug delivery mechanisms. Another notable patent is "Initial burst release controlled depot composition and a method thereof." This invention provides a depot composition that includes a hydrophobic amino acid in a microsphere, capable of controlling the initial burst release of an active ingredient. The composition is designed to maintain excellent suspending ability, ensuring that the active ingredient is delivered uniformly and continuously, even when used as an injectable formulation.
Career Highlights
Duck Soo Lim is currently associated with Tionlab Therapeutics, where he continues to innovate in the field of drug delivery. His work is characterized by a commitment to enhancing the efficacy of medical treatments through advanced formulations.
Collaborations
Lim collaborates with talented individuals in his field, including coworkers Eun Joo Lee and Jin-ho Kim. Their combined expertise contributes to the success of their projects and the advancement of drug delivery technologies.
Conclusion
Duck Soo Lim's contributions to drug delivery systems exemplify the impact of innovative thinking in the medical field. His patents reflect a dedication to improving therapeutic outcomes through advanced formulations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile